A potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis

dc.contributor.authorThuan, Duong Thi Bich
dc.contributor.authorZayed, Hatem
dc.contributor.authorEid, Ali H.
dc.contributor.authorAbou-Saleh, Haissam
dc.contributor.authorNasrallah, G. K.
dc.contributor.authorMangoni, Arduino A.
dc.contributor.authorPintus, Gianfranco
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:39:34Z
dc.date.available2025-01-24T11:39:34Z
dc.date.issued2018
dc.description.abstractSystemic sclerosis (SSc), an autoimmune disease that is associated with a number of genetic and environmental risk factors, is characterized by progressive fibrosis and microvasculature damage in the skin, lungs, heart, digestive system, kidneys, muscles, joints, and nervous system. These abnormalities are associated with altered secretion of growth factor and profibrotic cytokines, such as transforming growth factor-beta (TGF-β), interleukin-4 (IL-4), platelet-derived growth factor (PDGF), and connective-tissue growth factor (CTGF). Among the cellular responses to this proinflammatory environment, the endothelial cells phenotypic conversion into activated myofibroblasts, a process known as endothelial to mesenchymal transition (EndMT), has been postulated. Reactive oxygen species (ROS) might play a key role in SSs-associated fibrosis and vascular damage by mediating and/or activating TGF-β-induced EndMT, a phenomenon that has been observed in other disease models. In this review, we identified and critically appraised published studies investigating associations ROS and EndMT and the presence of EndMT in SSc, highlighting a potential link between oxidative stress and EndMT in this condition. © 2007-2018 Frontiers Media S.A. All Rights Reserved.
dc.identifier.doihttps://doi.org/10.3389/fimmu.2018.01985
dc.identifier.eid2-s2.0-85054450341
dc.identifier.pmid30283435
dc.identifier.urihttp://hdl.handle.net/10938/29283
dc.language.isoen
dc.publisherFrontiers Media S.A.
dc.relation.ispartofFrontiers in Immunology
dc.sourceScopus
dc.subjectEndothelial-to-mesenchymal transition
dc.subjectOxidative stress
dc.subjectReactive oxygen species
dc.subjectScleroderma
dc.subjectSystemic sclerosis
dc.subjectCytokines
dc.subjectEndothelial cells
dc.subjectEpithelial-mesenchymal transition
dc.subjectHumans
dc.subjectInflammation mediators
dc.subjectScleroderma, systemic
dc.subjectTransforming growth factor beta
dc.subjectReactive oxygen metabolite
dc.subjectAutacoid
dc.subjectCytokine
dc.subjectCell activation
dc.subjectCell transformation
dc.subjectEndothelial to mesenchymal transition
dc.subjectHuman
dc.subjectNonhuman
dc.subjectReview
dc.subjectTgf beta signaling
dc.subjectDrug effect
dc.subjectEndothelium cell
dc.subjectEpithelial mesenchymal transition
dc.subjectImmunology
dc.subjectMetabolism
dc.titleA potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis
dc.typeReview

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-8007.pdf
Size:
1.14 MB
Format:
Adobe Portable Document Format